annual EBITDA:
$125.50M-$28.70M(-18.61%)Summary
- As of today (August 17, 2025), EVH annual EBITDA is $125.50 million, with the most recent change of -$28.70 million (-18.61%) on December 31, 2024.
- During the last 3 years, EVH annual EBITDA has risen by +$82.88 million (+194.49%).
- EVH annual EBITDA is now -18.61% below its all-time high of $154.20 million, reached on December 31, 2023.
Performance
EVH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$12.77M+$41.48M(+144.49%)Summary
- As of today (August 17, 2025), EVH quarterly EBITDA is $12.77 million, with the most recent change of +$41.48 million (+144.49%) on June 30, 2025.
- Over the past year, EVH quarterly EBITDA has dropped by -$23.57 million (-64.86%).
- EVH quarterly EBITDA is now -96.60% below its all-time high of $375.20 million, reached on December 31, 2015.
Performance
EVH quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$8.11M-$23.57M(-74.39%)Summary
- As of today (August 17, 2025), EVH TTM EBITDA is $8.11 million, with the most recent change of -$23.57 million (-74.39%) on June 30, 2025.
- Over the past year, EVH TTM EBITDA has dropped by -$56.93 million (-87.52%).
- EVH TTM EBITDA is now -97.68% below its all-time high of $350.45 million, reached on December 31, 2015.
Performance
EVH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EVH EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -18.6% | -64.9% | -87.5% |
3 y3 years | +194.5% | -1.4% | -86.2% |
5 y5 years | +445.0% | +107.0% | +101.8% |
EVH EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -18.6% | +194.5% | -64.9% | +127.8% | -89.8% | +120.2% |
5 y | 5-year | -18.6% | +445.0% | -64.9% | +107.0% | -89.8% | +101.8% |
alltime | all time | -18.6% | +314.6% | -96.6% | +106.3% | -97.7% | +101.8% |
EVH EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $12.77M(-144.5%) | $8.11M(-74.4%) |
Mar 2025 | - | -$28.70M(-337.4%) | $31.68M(-60.0%) |
Dec 2024 | $125.50M(-18.6%) | $12.09M(+1.2%) | $79.17M(+30.1%) |
Sep 2024 | - | $11.96M(-67.1%) | $60.85M(-6.4%) |
Jun 2024 | - | $36.34M(+93.5%) | $65.04M(+62.6%) |
Mar 2024 | - | $18.79M(-401.7%) | $40.00M(-261.4%) |
Dec 2023 | $154.20M(+61.8%) | -$6.23M(-138.6%) | -$24.79M(+862.5%) |
Sep 2023 | - | $16.14M(+42.9%) | -$2.58M(-93.6%) |
Jun 2023 | - | $11.30M(-124.6%) | -$40.16M(+4.3%) |
Mar 2023 | - | -$46.00M(-387.8%) | -$38.51M(-286.1%) |
Dec 2022 | $95.31M(+123.6%) | $15.98M(-174.5%) | $20.69M(-28.2%) |
Sep 2022 | - | -$21.44M(-265.6%) | $28.83M(-50.9%) |
Jun 2022 | - | $12.95M(-1.9%) | $58.69M(+1.3%) |
Mar 2022 | - | $13.20M(-45.3%) | $57.91M(+3.8%) |
Dec 2021 | $42.62M(+41.9%) | $24.12M(+186.5%) | $55.82M(+24.0%) |
Sep 2021 | - | $8.42M(-30.8%) | $45.03M(+103.0%) |
Jun 2021 | - | $12.17M(+9.6%) | $22.19M(-112.8%) |
Mar 2021 | - | $11.11M(-16.7%) | -$173.84M(-27.8%) |
Dec 2020 | $30.02M(-182.5%) | $13.33M(-192.4%) | -$240.74M(-47.5%) |
Sep 2020 | - | -$14.42M(-92.2%) | -$458.13M(+1.5%) |
Jun 2020 | - | -$183.85M(+229.5%) | -$451.26M(+61.7%) |
Mar 2020 | - | -$55.80M(-72.7%) | -$279.00M(+9.6%) |
Dec 2019 | -$36.37M | -$204.06M(+2603.2%) | -$254.52M(+404.7%) |
Sep 2019 | - | -$7.55M(-34.9%) | -$50.43M(+14.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2019 | - | -$11.59M(-63.0%) | -$44.09M(+38.9%) |
Mar 2019 | - | -$31.32M(<-9900.0%) | -$31.76M(+664.8%) |
Dec 2018 | $68.22M(-383.4%) | $27.00K(-102.2%) | -$4.15M(-60.9%) |
Sep 2018 | - | -$1.22M(-262.2%) | -$10.61M(-32.2%) |
Jun 2018 | - | $749.00K(-120.2%) | -$15.64M(-45.9%) |
Mar 2018 | - | -$3.71M(-42.3%) | -$28.94M(-28.4%) |
Dec 2017 | -$24.07M(-58.8%) | -$6.43M(+3.0%) | -$40.40M(-34.4%) |
Sep 2017 | - | -$6.25M(-50.2%) | -$61.56M(-8.9%) |
Jun 2017 | - | -$12.55M(-17.3%) | -$67.60M(+5.9%) |
Mar 2017 | - | -$15.18M(-45.0%) | -$63.81M(-71.0%) |
Dec 2016 | -$58.48M(+63.3%) | -$27.59M(+124.6%) | -$220.06M(-220.4%) |
Sep 2016 | - | -$12.29M(+40.3%) | $182.73M(+1.1%) |
Jun 2016 | - | -$8.76M(-94.9%) | $180.82M(+1.0%) |
Mar 2016 | - | -$171.43M(-145.7%) | $179.03M(-48.9%) |
Dec 2015 | -$35.81M(<-9900.0%) | $375.20M(-2744.1%) | $350.45M(-1516.3%) |
Sep 2015 | - | -$14.19M(+34.4%) | -$24.75M(+134.4%) |
Jun 2015 | - | -$10.55M(<-9900.0%) | -$10.55M(<-9900.0%) |
Mar 2015 | - | $0.00(0.0%) | $0.00(-100.0%) |
Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | -$10.99M(0.0%) |
Sep 2014 | - | $0.00(0.0%) | -$10.99M(0.0%) |
Jun 2014 | - | $0.00(-100.0%) | -$10.99M(0.0%) |
Mar 2014 | - | -$10.99M | -$10.99M |
Dec 2013 | -$19.95M(+5.5%) | - | - |
Dec 2012 | -$18.91M | - | - |
FAQ
- What is Evolent Health, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Evolent Health, Inc.?
- What is Evolent Health, Inc. annual EBITDA year-on-year change?
- What is Evolent Health, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Evolent Health, Inc.?
- What is Evolent Health, Inc. quarterly EBITDA year-on-year change?
- What is Evolent Health, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Evolent Health, Inc.?
- What is Evolent Health, Inc. TTM EBITDA year-on-year change?
What is Evolent Health, Inc. annual EBITDA?
The current annual EBITDA of EVH is $125.50M
What is the all time high annual EBITDA for Evolent Health, Inc.?
Evolent Health, Inc. all-time high annual EBITDA is $154.20M
What is Evolent Health, Inc. annual EBITDA year-on-year change?
Over the past year, EVH annual EBITDA has changed by -$28.70M (-18.61%)
What is Evolent Health, Inc. quarterly EBITDA?
The current quarterly EBITDA of EVH is $12.77M
What is the all time high quarterly EBITDA for Evolent Health, Inc.?
Evolent Health, Inc. all-time high quarterly EBITDA is $375.20M
What is Evolent Health, Inc. quarterly EBITDA year-on-year change?
Over the past year, EVH quarterly EBITDA has changed by -$23.57M (-64.86%)
What is Evolent Health, Inc. TTM EBITDA?
The current TTM EBITDA of EVH is $8.11M
What is the all time high TTM EBITDA for Evolent Health, Inc.?
Evolent Health, Inc. all-time high TTM EBITDA is $350.45M
What is Evolent Health, Inc. TTM EBITDA year-on-year change?
Over the past year, EVH TTM EBITDA has changed by -$56.93M (-87.52%)